$VINC

Vincerx Pharma Inc

  • NASDAQ

PRICE

$1.77 -

Last Close

VOLUME

61,111

DAY RANGE

1.67 - 1.8

52 WEEK

1.67 - 18.43

Join Discuss about VINC with like-minded investors

profile
@EmporosAdmin #Emporos Research
recently

*BioPharma Play* $VINC

134 Replies 10 👍 12 🔥

profile
@dros #droscrew
recently

+Initiations 1/6: $ARDX $AYX $DNMR $KDNY $LAZR $NBTX $NLTX $OPEN $PTGX $SCYX $SEIC $SRRK $VINC $VLDR $VSTO $WELL . -Initiations 1/6: $SCCO

118 Replies 14 👍 12 🔥

Key Metrics

Market Cap

37.27 M

Beta

1.39

Avg. Volume

79.01 K

Shares Outstanding

21.06 M

Yield

0%

Public Float

0

Next Earnings Date

Next Dividend Date

Company Information

Vincerx Pharma (Vincerx) is a recently formed clinical-stage life sciences company focused on leveraging its extensive development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. Vincerx’s executive team has assembled a management team of biopharmaceutical experts with extensive experience in building and operating organizations that develop and deliver innovative medicines to patients. Vincerx’s current pipeline is derived from an exclusive license agreement with Bayer and includes a clinical-stage and follow-on small molecule drug program and a preclinical stage bioconjugation/next-generation antibody-drug conjugate platform. The company intends to develop multiple products through clinical proof-of-concept and potentially through Accelerated Approval in the United States.

Website:

HQ: ,

Related News